Compare Humana Inc (HUM) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Thomson Reuters Corp — how do they compare? Humana Inc trades at $404.09 (market cap $47.81B), while Thomson Reuters Corp trades at $92.62 (market cap $41.28B). The key difference: Humana Inc is the larger of the two by market cap, and Thomson Reuters Corp pays the higher dividend (2.75%). Which is the better fit depends on your goals.
| HUM | TRI | |
|---|---|---|
Market Cap | $47.81B | $41.28B |
Sector | Health | Industrials |
52-Week High | $409.42 | $205.54 |
52-Week Low | $163.67 | $76.55 |
Enterprise Value | $56.85B | $43.24B |
Dividend Yield | 0.89% | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Thomson Reuters (TRI) trades at $95.43, down 0.8% today, with a bullish technical signal and strong analyst consensus. The stock shows robust profitability with a 19.93% net margin and has beaten earnings estimates in two of the last three quarters. Recent corporate actions include a special dividend and a reverse stock split, while news highlights AI integration and a joint venture with KKR.
Outlook is positive with a consensus price target of $129.96 implying 36% upside, supported by solid cash flow and debt reduction. Risks include execution of AI strategy and competitive pressures. Wall Street sentiment is bullish with 52% buy ratings, but investors should monitor Q2 2026 earnings due August 5 for confirmation of growth trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
